Stevanato Group S.p.A.

Stevanato Group S.p.A. provides design, production, and distribution of products and processes for the biopharma and healthcare industries. Its business is organized into two segments: Biopharmaceutical and Diagnostic Solutions, and Engineering. The company offers drug containment solutions such as pre-fillable syringes, cartridges, vials, and ampoules. It also provides in-vitro diagnostic solutions, drug delivery systems including pen injectors, auto-injectors, and wearable injectors, as well as diagnostic laboratory consumables. Additionally, Stevanato offers analytical and regulatory support services, medical devices, pharmaceutical visual inspection machines, assembling and packaging machines, glass converting machines, and after-sales services like line optimization, training, logistics, spare parts, and maintenance. The company also provides contract development and manufacturing services for customer-owned drug delivery devices.

Stevanato Group S.p.A. is listed on the New York Stock Exchange (NYSE) under the ticker symbol STVN. The company's stock is traded in US Dollars (USD). This listing provides investors with access to the company's shares in the US market, despite the company being headquartered in Italy.

Stevanato Group operates in the Healthcare sector, specifically within the Medical Instruments & Supplies industry. This means the company is involved in manufacturing and supplying medical instruments, equipment, and supplies used by healthcare providers. Its products and services support pharmaceutical, biotechnology, diagnostics, and life sciences companies, as well as contract manufacturers of drug products, glass packaging, and fill and finish services.

Stevanato Group S.p.A. is headquartered in Piombino Dese, Italy. The company serves a global market, including Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. Founded in 1949, the company has a long history of providing solutions to the biopharma and healthcare industries worldwide. It operates as a subsidiary of Stevanato Holding S.R.L.

Stevanato Group generates revenue through two main segments: Biopharmaceutical and Diagnostic Solutions, and Engineering. The Biopharmaceutical and Diagnostic Solutions segment offers drug containment products (pre-fillable syringes, cartridges, vials, ampoules), drug delivery systems (pen injectors, auto-injectors, wearable injectors), diagnostic consumables, and analytical/regulatory support services. The Engineering segment provides pharmaceutical visual inspection machines, assembling and packaging machines, glass converting machines, and after-sales services such as line optimization, training, logistics, spare parts, and maintenance. Additionally, the company offers contract development and manufacturing services for customer-owned drug delivery devices. Its customers include pharmaceutical, biotechnology, diagnostics, and life sciences companies, as well as contract manufacturers.